Entry |
|
Name |
Efavirenz, lamivudine and tenofovir disoproxil fumarate; Symfi (TN) |
Product |
|
Generic |
|
Component |
|
Class |
|
Remark |
|
Efficacy |
Antiviral |
Disease |
|
Target |
HIV-1 reverse transcriptase [KO: K24802] |
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR11 Lamivudine, tenofovir disoproxil and efavirenz
D11392 Efavirenz, lamivudine and tenofovir disoproxil fumarate <US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Combinations
Efavirenz/ Lamivudine/ Tenofovir Disoproxil Fumarate
D11392 Efavirenz, lamivudine and tenofovir disoproxil fumarate
Drug groups [BR:br08330]
Antiviral
DG03107 Anti-HIV agent
D11392 Efavirenz, lamivudine and tenofovir disoproxil fumarate
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D11392 Efavirenz, lamivudine and tenofovir disoproxil fumarate
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D11392 Efavirenz, lamivudine and tenofovir disoproxil fumarate <US>
|
Other DBs |
|
LinkDB |
|